GlassScriptPhysician profile
Jared A Hertz
NPI 1164782108
$4,458.19
in general payments reported to CMS, 2019-2025
44 companies · $870 in 2025
The $870 reported for 2025 was more than what 83% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $777 · 2020: $194 · 2021: $612 · 2022: $648 · 2023: $794 · 2024: $563 · 2025: $870.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,227.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intra-Sana Laboratories | $586.62 | 2023-2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Astrazeneca Pharmaceuticals LP | $488.50 | 2020-2025 | Farxiga, Airsupra |
| Sanofi-Aventis U.S. LLC | $469.64 | 2019 | |
| Biotronik INC. | $356.47 | 2019-2021 | |
| Exact Sciences Corporation | $270.46 | 2023-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $180.88 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Welch Allyn | $175.98 | 2021 | |
| Novo Nordisk INC | $152.65 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Intuity Medical INC | $149.99 | 2022 | |
| Lilly USA, LLC | $147.50 | 2019-2025 | Zepbound, Mounjaro |
| Otsuka America Pharmaceutical, INC. | $124.65 | 2022-2025 | Rexulti |
| Janssen Pharmaceuticals, INC | $111.83 | 2019-2023 | Xarelto |
| Pfizer INC. | $91.22 | 2022-2025 | |
| Baxter Healthcare | $87.99 | 2022 | |
| W. L. Gore & Associates, INC. | $86.13 | 2023 | Gore Synecor Biomaterial |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Hertz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.